Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance
- PMID: 26291638
- PMCID: PMC4550160
- DOI: 10.3201/eid2109.150512
Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance
Abstract
Across the United States, antimicrobial drug-resistant infections affect a diverse population, and effective interventions require concerted efforts across various public health and clinical programs. Since its onset in 1994, the Centers for Disease Control and Prevention Emerging Infections Program has provided robust and timely data on antimicrobial drug-resistant infections that have been used to inform public health action across a spectrum of partners with regard to many highly visible antimicrobial drug-resistance threats. These data span several activities within the Program, including respiratory bacterial infections, health care-associated infections, and some aspects of foodborne diseases. These data have contributed to estimates of national burden, identified populations at risk, and determined microbiological causes of infection and their outcomes, all of which have been used to inform national policy and guidelines to prevent antimicrobial drug-resistant infections.
Keywords: EIP; Emerging Infections Program; antimicrobial resistance; bacteria; health care–associated infection; surveillance.
References
-
- Institute of Medicine (US) Committee on Emerging Microbial Threats to Health. In: Lederberg J, Shope RE, Oaks SC, editors. Emerging infections: microbial threats to health in the United States. Washington (DC): National Academies Press (US); 1992. - PubMed
-
- Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. [cited 2015 Mar 3]. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical